Patents Assigned to Orient Bio., Inc.
  • Patent number: 7626076
    Abstract: The disclosure concerns a method for resistance of epilepsy by suppressing the function of alpha 1G protein of T-type calcium channels, use of suppressor of alpha 1G protein for prevention or treatment for epilepsy, knockout mice resisting epilepsy by disrupting alpha 1G subunit of T-type calcium channel, and preparation method thereof. The ?1G-knockout transgenic mouse can be used for investigating the relationship between diseases particularly neuropathy or psychopathy and the function of ?1G T-type calcium channel via various behavioral tests since ?1G subunit is mainly expression in central nervous system (CNS) and pheripheral nervous system (PNS). Further, the ?1G-knockout transgenic mouse can be used for screening antileptic agents.
    Type: Grant
    Filed: November 23, 2007
    Date of Patent: December 1, 2009
    Assignee: Orient Bio., Inc.
    Inventors: Hee-Sup Shin, Daesoo Kim, Sehoon Keum, Inseon Song